Cytogen, Inc. (KOSDAQ:217330)
5,710.00
+130.00 (2.33%)
At close: Apr 28, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 131.73 billion as of April 29, 2026. Its market cap has increased by 66.96% in one year.
Market Cap
131.73B
Enterprise Value
116.92B
Revenue
26.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,710.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 131.73B, an increase of 49.88%. That is a compound annual growth rate of 5.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Panagene | 100.26B |
| GENINUS | 182.56B |
| Green Cross Medical Science | 85.23B |
| Inventera | 195.46B |
| Protia | 63.36B |
| Seoulin Bioscience | 57.20B |
| GeneMatrix | 42.42B |
| 3billion | 415.76B |